There are distinct differences between multisource proteins and chemical generics. The BioGeneriX AG faces the challenge of higher development costs, time-to-market, quality requirements, as well as demanding approval and patent procedures. The cornerstones of our organization are project management, biotechnological know-how, expertise in legal and patent matters, business intelligence and the management of alliances.  "A key element is our own development laboratory where we work intensively on projects in cell biology and protein chemistry, design new processes and evaluate new projects. The successful completion of our first development project confirmed the long-term orientation of our set-up. Three further pharmaceuticals are currently under development in collaboration with our partners." Dr. Erich Kohler Pharmacist, Head of Development Biotechnology